COVID-19 Research
Preparation of Disease management Manual for Primary Health Centers (PHCs) and Hospitals
Targeting n3CLPro main protease, spike surface protein of COVID-19 In silico screening of FDA approved compounds
Designing virus-like particles as vaccine candidates against nCoV-19 Proposed express M (Membrane), N (Nucleocapsid), E (Envelope) and S (Spike) proteins of nCoV-19 simultaneously in HEK293 cells for generating virus-like particle
Computational prediction of possible nCoV-19 structural proteins inhibitors from Azadirachta indica (Neem) Five potential compounds screened for CL-3 protease protein of nCov19
Creating candidate vaccine against the COVID-19
Adapt Ubiqare?s Specialty Care Platform to take care of COVID-19 patients during home quarantine and isolation ward stage
A Novel First AId Technique for Treating COVID-19
Identification of global metabolite biomarkers in COVID-19 infected patients for targeted therapy
Plasma Proteomic Analysis of COVID-19 patients to identify the potential biomarkers and therapeutic targets
In-situ Gel for Rapid Capture and Inactivation of 2019-nCoV
Pages
